Neuronetics is trading at $2.14, down -12.11%, amid a sharp technology-led selloff linked to investor concerns about AI regulation and data-center investment.
- No new company-specific announcement explaining the November 6 move surfaced in the search. Neuronetics’ November 4 results were positive, with higher revenue and improved margin guidance, but do not clearly explain the drop.
- The prior session saw 1,546,611 shares traded; pre-market volume was unavailable in the sources reviewed.